1. Safety and immunogenicity of an inactivated influenza A (H5N1) vaccine;Treanor;New Engl J Med,2006
2. Confronting the avian influenza threat: vaccine development for a potential pandemic;Stephenson;Lancet Infect Dis,2004
3. de Jong JC, Palache AM, Beyer WEP, Rimmelzwaan GF, Boon ACM, Osterhous ADME. Haemagglutination-inhibiting antibody to influenza virus. In: Brown F, Haaheim LR, Schild GC, editors. Laboratory correlates of immunity to influenza-reassessment, vol. 115. Dev. Biol. Basel, Karger; 2003. p. 63–73.
4. Update on avian influenza A (H5N1) virus infection in humans. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus;Abdel-Ghafar;New Engl J Med,2008
5. WHO Guidelines on regulatory preparedness for human pandemic influenza vaccines. WHO Technical Report Series, in press.